BioStem is dedicated to the relentless pursuit of healing through our commitment to innovation and quality.
Since 2014, BioStem Technologies, Inc. has been a leading biomedical innovator, trusted by clinicians across specialties to deliver best-in-class solutions for advanced Surgical Care and advanced Wound Care. We’re passionate about boldly advancing innovation while upholding the principles of good stewardship that have led to us to where we are today, delivering high quality placental allograft products that inspire confidence in our clinicians and partners and help patients improve their lives.
NEWS & EVENTS:
BIOSTEM IN THE NEWS
Don’t miss an opportunity to catch up with the latest developments in Wound Care and Surgical Care.
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
MKTG-047v01